Clinical Trials

Randomized phase 2 trial of gemcitabine + carboplatin + nivolumab versus gemcitabine + oxaliplatin + nivolumab in cisplatin-ineligible patients with metastatic urothelial cancer


Study ID
Tesaro 4020-01-001

NCT Number
NCT02817633 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0298

Principle Investigator
Dr. Martin Gutierrez

Phase
I

Sponsor
Tesaro


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now